Florica Therapeutics, Inc. Awarded Competitive Grant from the National Science Foundation to Study Brain-Immune Axis in COVID-19

SAN FRANCISCO--(BUSINESS WIRE)-- #MBCBiolabs--Florica Therapeutics, Inc. has been awarded a $255,678 NSF SBIR grant to work on hypothalamus stem cell exosomes for the treatment of COVID-19.

Click to view original post